Full View

Thrombocyte transfusion and rebleeding rate in patients using antiplatelet agents before aneurysmal subarachnoid hemorrhage

M Sebök, N Zaugg, E Keller, J Willms, L Regli… - Neurosurgical …, 2023 - thejns.org
OBJECTIVE The reason for a rebleed after an initial hemorrhage in patients with aneurysmal
subarachnoid hemorrhage (aSAH) is considered multifactorial. Antiplatelet use is one of the …
被引用次数：2 相关文章

Thrombocyte transfusion and rebleeding rate in patients using antiplatelet agents before aneurysmal subarachnoid hemorrhage.

M Sebök, N Zaugg, E Keller, J Willms, L Regli… - Neurosurgical …, 2023 - europepmc.org
Objective The reason for a rebleed after an initial hemorrhage in patients with aneurysmal
subarachnoid hemorrhage (aSAH) is considered multifactorial. Antiplatelet use is one of the …
[PDF] researchgate.net

[PDF][PDF] Thrombocyte transfusion and rebleeding rate in patients using antiplatelet agents before aneurysmal subarachnoid hemorrhage

M Sebök, N Zaugg, E Keller, J Willms, L Regli - Neurosurg Focus, 2023 - researchgate.net
OBJECTIVE The reason for a rebleed after an initial hemorrhage in patients with aneurysmal
subarachnoid hemorrhage (aSAH) is considered multifactorial. Antiplatelet use is one of the …

Thrombocyte transfusion and rebleeding rate in patients using antiplatelet agents before aneurysmal subarachnoid hemorrhage

M Sebök, N Zaugg, E Keller, J Willms… - Neurosurgical …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective The reason for a rebleed after an initial hemorrhage in patients with aneurysmal
subarachnoid hemorrhage (aSAH) is considered multifactorial. Antiplatelet use is one of the …

Thrombocyte transfusion and rebleeding rate in patients using antiplatelet agents before aneurysmal subarachnoid hemorrhage

M Sebök, N Zaugg, E Keller, J Willms, L Regli… - Neurosurgical …, 2023 - zora.uzh.ch
OBJECTIVE The reason for a rebleed after an initial hemorrhage in patients with aneurysmal
subarachnoid hemorrhage (aSAH) is considered multifactorial. Antiplatelet use is one of the …